http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010005717-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-08
filingDate 2008-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_209259f9f93ce12923b6dae8f91c4a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7349ea829414967d1686f0aeaeb81a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d361c8cd448909c6953bdb08cd51e78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a7fd2923c9bdbac3f262bd97957c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd53ce2c4146d033830f604a531158d1
publicationDate 2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010005717-A
titleOfInvention DERIVATIVES OF ISOXAZOLO-PIRIDINA.
abstract The present invention relates to isoxazol-pyridine derivatives of the formula I (see formula (I)) in which X, from R1 to R6 have the meanings defined in claim 1. These compounds are active at the receptor binding site GABA A5 and are useful for the treatment of cognitive disorders, for example Alzheimer's disease.
priorityDate 2007-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22574589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452923700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414040771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66619066

Total number of triples: 40.